drugset / Trial / NCT00457652

Does Caffeine Reduce Rosuvastatin-Induced Protection Against Ischemia-Reperfusion Injury?

NCT00457652

Phase 4 Completed 24 enrolled Radboud University Medical Center
RandomizedParallel-groupQuadruple-blindPrevention

Summary

Does caffeine reduce rosuvastatin induced protection against ischemia reperfusion injury?

Timeline

Start
2007-06
Primary completion
2007-09
Completion
2007-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Rosuvastatin Small molecule 20 mg

Indications